JP Morgan Chase’s Hologic HOLX Stock Holding History

JP Morgan Chase’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-300	Closed	-$19.5K	–	7548
2025 Q2	$19.5K	Buy	+300	New	+$18K	﹤0.01%	6182
2023 Q1	–	Sell	-175,500	Closed	-$13.1M	–	6939
2022 Q4	$13.1M	Buy	+175,500	New	+$12.5M	﹤0.01%	2021
2021 Q4	–	Sell	-10,500	Closed	-$775K	–	6778
2021 Q3	$775K	Buy	+10,500	New	+$787K	﹤0.01%	4480
2020 Q4	–	Sell	-3,300	Closed	-$218K	–	5749
2020 Q3	$218K	Buy	+3,300	New	+$209K	﹤0.01%	4319
2019 Q2	–	Sell	-148,300	Closed	-$7.18M	–	5855
2019 Q1	$7.18M	Buy	+148,300	New	+$6.69M	﹤0.01%	2314

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's HOLX Position: Q2 2026 in Review

JP Morgan Chase sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,301,493 shares — an estimated $249M sold.

JP Morgan Chase first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $271M in Q2 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

JP Morgan Chase reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
JP Morgan Chase sold 3,301,493 Hologic shares in Q2 2026, an estimated $249M.
JP Morgan Chase first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
JP Morgan Chase's Hologic position peaked at $271M in Q2 2023.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.